Next report date
Report period
Q1 2024
EPS estimate
−0.84USD
Revenue estimate
—
−60.37 MUSD
30.35 M
About Kyverna Therapeutics, Inc.
Sector
Industry
CEO
Peter K. Maag
Website
Headquarters
Emeryville
Employees (FY)
96
FIGI
BBG00RCYMHR1
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KYTX is 16.61 USD — it has increased by 9.71% in the past 24 hours. Watch Kyverna Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Kyverna Therapeutics, Inc. stocks are traded under the ticker KYTX.
Kyverna Therapeutics, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
KYTX stock is 12.77% volatile and has beta coefficient of −0.21. Track Kyverna Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Kyverna Therapeutics, Inc. there?
Yes, you can track Kyverna Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
KYTX stock has fallen by 13.49% compared to the previous week, the month change is a 32.62% fall, over the last year Kyverna Therapeutics, Inc. has showed a 51.50% decrease.
KYTX net income for the last quarter is −20.67 M USD, while the quarter before that showed −8.50 M USD of net income which accounts for −143.26% change. Track more Kyverna Therapeutics, Inc. financial stats to get the full picture.
Today Kyverna Therapeutics, Inc. has the market capitalization of 716.14 M, it has decreased by 13.06% over the last week.
No, KYTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KYTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kyverna Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
KYTX reached its all-time high on Feb 8, 2024 with the price of 35.06 USD, and its all-time low was 15.43 USD and was reached on Apr 26, 2024. View more price dynamics on KYTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 96.00 employees. See our rating of the largest employees — is Kyverna Therapeutics, Inc. on this list?
We've gathered analysts' opinions on Kyverna Therapeutics, Inc. future price: according to them, KYTX price has a max estimate of 48.00 USD and a min estimate of 39.00 USD. Watch KYTX chart and read a more detailed Kyverna Therapeutics, Inc. stock forecast: see what analysts think of Kyverna Therapeutics, Inc. and suggest that you do with its stocks.